These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8592328)

  • 1. Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).
    de Silva D; Gilbert F; Needham G; Deans H; Turnpenny P; Haites N
    J Med Genet; 1995 Nov; 32(11):862-6. PubMed ID: 8592328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?
    Hemminki K; Granström C
    Breast Cancer Res; 2002; 4(4):R7. PubMed ID: 12100745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological features of breast cancer in Al-Madinah region of Saudi Arabia.
    Albasri A; Hussainy AS; Sundkji I; Alhujaily A
    Saudi Med J; 2014 Dec; 35(12):1489-93. PubMed ID: 25491214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic diseases in families of breast cancer patients.
    Tulinius H; Olafsdottir GH; Sigvaldason H; Tryggvadottir L; Bjarnadottir K
    J Med Genet; 1994 Aug; 31(8):618-21. PubMed ID: 7815419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
    Møller P; Evans G; Haites N; Vasen H; Reis MM; Anderson E; Apold J; Hodgson S; Eccles D; Olsson H; Stoppa-Lyonnet D; Chang-Claude J; Morrison PJ; Bevilacqua G; Heimdal K; Maehle L; Lalloo F; Gregory H; Preece P; Borg A; Nevin NC; Caligo M; Steel CM
    Dis Markers; 1999 Oct; 15(1-3):207-11. PubMed ID: 10595280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
    Brekelmans CT; Bartels CC; Crepin E; van Geel AN; Meijers-Heijboer H; Seynaeve C; Tilanus-Linthorst MM; Verhoog LC; Wagner A; Klijn JG
    Dis Markers; 1999 Oct; 15(1-3):34-6. PubMed ID: 10595248
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of outcome of mammography in the National Health Service Breast Screening Programme.
    Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M
    J Med Screen; 2002; 9(2):74-82. PubMed ID: 12133927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the population dose to the UK population from the National Health Service Breast Screening Programme.
    Faulkner K; Wallis MG; Neilson F; Whitaker CJ
    Radiat Prot Dosimetry; 2008; 129(1-3):184-90. PubMed ID: 18483008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paget's disease of the breast.
    Thorson AG; Karrer FW; Moor BJ; Rose SG; Blatchford G; Oliverius J
    Nebr Med J; 1983 Apr; 68(4):80-4. PubMed ID: 6302526
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.
    Bennett IC; Muller J; Cockburn L; Joshua H; Thorley G; Baker C; Wood N; Brazier J; Jones M; Dunn N; Gattas M
    World J Surg; 2010 May; 34(5):979-86. PubMed ID: 20108093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audit of women attending the Aberdeen Genetic Clinic with a family history of breast cancer who subsequently develop cancer.
    Gregory H; Gibbons B; Haites N
    Dis Markers; 1999 Oct; 15(1-3):201-3. PubMed ID: 10595279
    [No Abstract]   [Full Text] [Related]  

  • 14. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
    Childers KK; Maggard-Gibbons M; Macinko J; Childers CP
    JAMA Oncol; 2018 Jun; 4(6):876-879. PubMed ID: 29710084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
    Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
    J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic density and estimation of breast cancer risk in intermediate risk population.
    Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
    Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
    Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
    J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.